GENRX ROXITHROMYCIN roxithromycin 150 mg film coated tablets blister pack

Krajina: Austrália

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktívna zložka:

roxithromycin, Quantity: 150 mg

Dostupné z:

Arrotex Pharmaceuticals Pty Ltd

INN (Medzinárodný Name):

Roxithromycin

Forma lieku:

Tablet, film coated

Zloženie:

Excipient Ingredients: hyprolose; purified talc; maize starch; glucose; colloidal anhydrous silica; sodium starch glycollate type A; sodium starch glycollate type B; titanium dioxide; hypromellose; magnesium stearate; povidone; propylene glycol; poloxamer

Spôsob podávania:

Oral

Počet v balení:

10 tablets

Typ predpisu:

(S4) Prescription Only Medicine

Terapeutické indikácie:

Adults: Roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: Upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. Lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. Skin and skin structure infections. Nongonococcal urethritis. Children: ROXITHROMYCIN 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible microorganisms: Acute pharyngitis. Acute tonsillitis, impetigo. Appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. Therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

Prehľad produktov:

Visual Identification: White to off-white, round, convex film coated tablets.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Stav Autorizácia:

Licence status A

Dátum Autorizácia:

2008-04-10